Latest filing published 15 Feb 2022 for Bioventus Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Gregory O. Anglum: trading record in brief
This profile gathers the share dealings of Gregory O. Anglum in Bioventus Inc., where the filings describe the role as senior executive. Between 11 February 2021 and 14 February 2022, the trades on record add up to 5 filings.
The open-market side counts 1 purchase for €64k alongside 1 sale for €14k. On balance, insiders were net buyers of €51k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant and 2 option exercises. So far in 2022, the count stands at no purchases and 1 sale.
Most recently, on 15 February 2022, the filings show an open-market sale worth €14k in Bioventus Inc. The last purchase on record was published on 5 April 2021, which is 2,044 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gregory O. Anglum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,400 sharesClass A Common StockSEC:0000899243-22-006541:0
- 65,581 sharesClass A Common StockSEC:0000899243-22-006327:0
2 of 2 declarations
